Asked
How many Admiral Nurses are currently employed in England, broken down by Integrated Care Board.
Reply
Awaiting answer.
The Westminster lensArchive · Written questions · 4,196 tabled · 3,904 answered
Written questions by McMurdock.
Every parliamentary written question tabled by James McMurdock this session, with the full answer and department. See how every department answers, or back to the MP page.
Department:All (4,196)Ministry of Housing, Communities and Local Government (578)Department of Health and Social Care (526)Home Office (452)Department for Education (432)Department for Work and Pensions (255)Department for Transport (248)Treasury (247)Department for Environment, Food and Rural Affairs (221)Foreign, Commonwealth and Development Office (209)Department for Business and Trade (206)Ministry of Justice (203)Department for Energy Security and Net Zero (194)
Showing 1–20 of 526 · Department of Health and Social Care
Page 1 of 27Next →
Asked
What comparative assessment he has made of access to Admiral Nurses across regions in England.
Reply
Awaiting answer.
Asked
What steps is he taking to increase access to specialist dementia nursing support in areas where provision is limited.
Reply
Awaiting answer.
Asked
What assessment he has made of the adequacy of the provision of Admiral Nurses across England.
Reply
Awaiting answer.
Asked
What steps he is taking to improve access to long-term support services for people living with rare cancers.
Reply
Awaiting answer.
Asked
What the median waiting time was from GP referral to confirmed diagnosis for patients diagnosed with sarcoma in the latest period for which data is available.
Reply
Awaiting answer.
Asked
What steps he is taking when ambulance handover times at Basildon Hospital exceed the NHS England 45-minute maximum.
Reply
Awaiting answer.
Asked
What assessment he has made of the potential impact of ambulance handover delays at Basildon Hospital on ambulance response times in the East of England Ambulance Service area.
Reply
Awaiting answer.
Asked
What steps he is taking to measure the effectiveness of Hospital Ambulance Liaison Officers at Basildon Hospital.
Reply
Awaiting answer.
Asked
What assessment he has made of the potential impact on patient outcomes of the availability of Enhertu on the NHS.
Reply
Ministers met with the manufacturers of Enhertu, AstraZeneca, and Daiichi Sankyo, in November 2024 to encourage them to engage constructively with NHS England and the National Institute for Health and Care Excellence (NICE) to reach a commercial agreement...
Asked
What recent discussions he has had with NHS officials and pharmaceutical companies on making Enhertu available on the NHS for patients with HER2-low metastatic breast cancer.
Reply
Ministers met with the manufacturers of Enhertu, AstraZeneca, and Daiichi Sankyo, in November 2024 to encourage them to engage constructively with NHS England and the National Institute for Health and Care Excellence (NICE) to reach a commercial agreement...
Asked
What estimate he has made of the number of patients who would become eligible for treatment if Enhertu were recommended for routine commissioning by the NHS.
Reply
In July 2024, the National Institute for Health and Care Excellence (NICE) estimated that approximately 1,000 to 1,500 people would have been eligible for treatment with trastuzumab deruxtecan (Enhertu) for HER2-low metastatic or unresectable breast cance...
Asked
What estimate he has made of the number of patients in Essex with HER2-low metastatic breast cancer who would be eligible for treatment with Enhertu were it to be routinely commissioned.
Reply
In July 2024, the National Institute for Health and Care Excellence (NICE) estimated that approximately 1,000 to 1,500 people would have been eligible for treatment with trastuzumab deruxtecan (Enhertu) for HER2-low metastatic or unresectable breast cance...
Asked
What estimate he has made of the annual cost to the NHS of routinely commissioning Enhertu for eligible patients.
Reply
In July 2024, the National Institute for Health and Care Excellence (NICE) estimated that approximately 1,000 to 1,500 people would have been eligible for treatment with trastuzumab deruxtecan (Enhertu) for HER2-low metastatic or unresectable breast cance...
Asked
What recent steps he has taken to improve patient access to innovative cancer medicines that have received regulatory approval.
Reply
Officials across the Department, NHS England, and the National Institute for Health and Care Excellence (NICE) regularly meet with patient groups to discuss medicines policy, access, and uptake, including with organisations representing individuals affect...
Asked
Whether NHS England is currently engaged in commercial negotiations with pharmaceutical providers on access to Enhertu.
Reply
Ministers met with the manufacturers of Enhertu, AstraZeneca, and Daiichi Sankyo, in November 2024 to encourage them to engage constructively with NHS England and the National Institute for Health and Care Excellence (NICE) to reach a commercial agreement...
Asked
What discussions he has had with patient organisations representing people with metastatic breast cancer on improving access to innovative cancer medicines.
Reply
Officials across the Department, NHS England, and the National Institute for Health and Care Excellence (NICE) regularly meet with patient groups to discuss medicines policy, access, and uptake, including with organisations representing individuals affect...
Asked
What assessment he has made of trends in the level of regional variation in ambulance handover performance in the East of England.
Reply
Data is regularly collected and published monthly on ambulance handover performance, both at ambulance trust and acute trust level. This data is available at the following two links:https://www.england.nhs.uk/statistics/statistical-work-areas/ambulance-qu...
Asked
What assessment he has made of the adequacy of the implementation of ambulance handover best practice guidance at Basildon Hospital.
Reply
Hospital handover delays are a significant driver of challenged ambulance performance. The East of England Ambulance Service Trust (EEAST) works closely with all its acute hospital partners, including Basildon and Thurrock University Hospital (BTUH), to i...
Asked
What measures will be used to assess the success of the patient plan in improving a) patient outcomes and b) ambulance response times.
Reply
The Government recognises that in past years, ambulance response times have not met the high standards patients should expect. We are addressing this challenge through the Medium Term Planning Framework (MTPF), closely aligned with the 10-Year Health Plan...
Page 1 of 27Next →
Sources
SourceUK Parliament Members API
MethodQuestion and answer text as published. Question preamble (“To ask the…”) trimmed for readability; answers shown in full.